TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says May 12, 1995
TCL Archive As Shutdown Nears, House Republicans Press For Deeper Cuts and Repeal of Obamacare September 13, 2013
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008